Compare ADMA Biologics Inc (ADMA) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Eli Lilly And Co — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Eli Lilly And Co trades at $1,212 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 486.5× ADMA Biologics Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | LLY | |
|---|---|---|
Market Cap | $2.22B | $1.08T |
Sector | Health | Health |
52-Week High | $20.38 | $1.24K |
52-Week Low | $7.60 | $639.43 |
Enterprise Value | $2.29B | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
